Schonfeld Strategic Advisors LLC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1665241 NEW YORK, NY

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,569,629

-$2,241,148 QoQ

Shares Held

95,242

-46.4% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#86

of 224 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. MLYS ranks #48 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,569,629	95,242	-46.4%	Shares	Sole	2026-08-14
2026-03-31	$4,810,777	177,585	+256.4%	Shares	Sole	2026-05-15
2025-12-31	$1,808,004	49,821	+240.8%	Shares	Sole	2026-02-17
2025-09-30	$554,314	14,618	-94.2%	Shares	Sole	2025-11-14
2025-06-30	$3,425,782	253,199	+16.4%	Shares	Sole	2025-08-14
2025-03-31	$3,453,296	217,462	+13.0%	Shares	Sole	2025-05-15
2023-09-30	$1,829,362	192,362	+64.3%	Shares	Sole	2023-11-14
2023-06-30	$1,996,793	117,114	+31.8%	Shares	Sole	2023-08-14
2023-03-31	$1,391,359	88,848	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.